Clinic
Frederiksted Health Care, INC.
Frederiksted Health Care, INC. was paid $24.36M by Medicaid between Jan 2018 and Nov 2024, across 176 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoFREDERIKSTED HEALTH CARE, INC.
FREDERIKSTED, VI 00840
FREDERIKSTED, VI 00840
33aNPI1437215134assigned 12/28/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$24.36M
24GClaims321,364
24DCodes billed176
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 49,872 | $3.53M | |
| 2019 | 58,843 | $4.56M | |
| 2020 | 47,646 | $2.72M | |
| 2021 | 46,095 | $3.74M | |
| 2022 | 51,239 | $4.65M | |
| 2023 | 36,675 | $2.81M | |
| 2024incomplete | 30,994 | $2.34M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 38,310 | 29,650 | $5.42M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 26,851 | 22,107 | $4.93M |
| 80053 | Comprehensive metabolic panel | 5.1% | 7,501 | 6,497 | $1.25M |
| 99000 | 3.4% | 29,427 | 22,663 | $834K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.0% | 7,226 | 5,372 | $729K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.5% | 7,168 | 5,924 | $611K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.5% | 7,009 | 5,810 | $599K |
| 36415 | Collection of venous blood by venipuncture | 2.1% | 26,267 | 21,620 | $502K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.0% | 2,930 | 2,410 | $475K |
| D1330 | 1.7% | 6,675 | 6,425 | $411K | |
| 80061 | Lipid panel | 1.6% | 5,908 | 5,153 | $383K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.5% | 1,365 | 1,202 | $368K |
164 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 4,743 | $352K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 1,960 | $351K |
| D0150 | Comprehensive oral evaluation - new or established patient | 1.3% | 3,493 | $308K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.2% | 1,635 | $289K |
| 81025 | 1.1% | 6,854 | $269K | |
| D0330 | Panoramic radiographic image | 1.1% | 2,963 | $265K |
| D0140 | Limited oral evaluation - problem focused | 1.1% | 3,886 | $262K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 1.1% | 1,436 | $261K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 1,580 | $240K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,085 | $237K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,699 | $223K |
| 82962 | <1% | 8,734 | $222K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 1,570 | $220K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 4,210 | $213K |
| 88142 | <1% | 1,556 | $210K | |
| D4341 | <1% | 923 | $195K | |
| D1310 | <1% | 5,341 | $175K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,394 | $170K |
| 83037 | <1% | 5,480 | $169K | |
| D1206 | Topical application of fluoride varnish | <1% | 5,017 | $161K |
| D1120 | Dental cleaning, child | <1% | 2,615 | $159K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 7,235 | $150K |
| 84439 | <1% | 2,237 | $134K | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 1,114 | $126K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 892 | $111K |
| D1351 | Sealant - per tooth | <1% | 1,973 | $104K |
| 80074 | <1% | 319 | $102K | |
| 59426 | <1% | 76 | $101K | |
| 59025 | Fetal non-stress test | <1% | 553 | $100K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 485 | $93K |
| 86592 | <1% | 4,652 | $92K | |
| D0274 | Bitewings - four radiographic images | <1% | 1,533 | $83K |
| 90461 | <1% | 4,152 | $81K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 859 | $80K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 3,257 | $76K |
| 81002 | <1% | 8,636 | $72K | |
| 85027 | <1% | 2,422 | $68K | |
| 99442 | <1% | 1,601 | $64K | |
| D1110 | Prophylaxis - adult | <1% | 695 | $60K |
| D0120 | Dental checkup, returning patient | <1% | 1,348 | $59K |
| 90837 | Psychotherapy session, about an hour | <1% | 205 | $57K |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 3,056 | $54K |
| D0180 | <1% | 695 | $52K | |
| 99441 | <1% | 1,348 | $50K | |
| D0190 | <1% | 985 | $44K | |
| 83655 | <1% | 1,455 | $43K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 229 | $43K |
| 87177 | <1% | 1,036 | $41K | |
| 96127 | <1% | 1,219 | $38K | |
| 99381 | <1% | 169 | $37K | |
| 81001 | <1% | 1,675 | $33K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 829 | $31K |
| 99173 | <1% | 1,560 | $28K | |
| 87209 | <1% | 785 | $27K | |
| 82607 | <1% | 291 | $25K | |
| D4910 | <1% | 218 | $24K | |
| 81003 | <1% | 1,188 | $24K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 113 | $24K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 80 | $23K |
| D9215 | <1% | 432 | $20K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 116 | $20K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 13 | $20K |
| 85014 | <1% | 1,171 | $19K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 81 | $19K |
| 59430 | <1% | 49 | $18K | |
| D1352 | <1% | 242 | $16K | |
| D0272 | Bitewings - two radiographic images | <1% | 431 | $16K |
| G0467 | Community health center visit, returning patient | <1% | 1,162 | $16K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 266 | $14K |
| D0270 | <1% | 677 | $13K | |
| 87536 | <1% | 43 | $12K | |
| 85018 | <1% | 1,024 | $12K | |
| 82043 | <1% | 280 | $11K | |
| 0012A | <1% | 223 | $11K | |
| 99443 | <1% | 251 | $11K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 28 | $8K |
| D9110 | <1% | 82 | $8K | |
| 97803 | <1% | 84 | $8K | |
| 90756 | <1% | 89 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 91 | $7K |
| 82746 | <1% | 75 | $7K | |
| 90750 | <1% | 12 | $7K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 26 | $6K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 13 | $5K |
| 82570 | <1% | 126 | $5K | |
| 86703 | <1% | 57 | $5K | |
| 84702 | <1% | 81 | $5K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 16 | $5K |
| 86360 | <1% | 42 | $5K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 40 | $5K |
| D1354 | <1% | 160 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 57 | $4K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 13 | $4K |
| 0011A | <1% | 189 | $4K | |
| 86762 | <1% | 80 | $4K | |
| 76801 | <1% | 18 | $4K | |
| 83020 | <1% | 41 | $4K | |
| 86850 | <1% | 107 | $4K | |
| 90715 | <1% | 50 | $3K | |
| 83986 | <1% | 56 | $3K | |
| D4342 | <1% | 22 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 66 | $3K |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 62 | $3K |
| 87340 | <1% | 105 | $3K | |
| 99382 | <1% | 23 | $3K | |
| 86900 | <1% | 87 | $3K | |
| 83021 | <1% | 68 | $3K | |
| 86803 | <1% | 42 | $3K | |
| 87088 | <1% | 59 | $3K | |
| 83525 | <1% | 25 | $3K | |
| 86677 | <1% | 12 | $2K | |
| 90658 | <1% | 50 | $2K | |
| 80055 | <1% | 13 | $2K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 80 | $2K |
| 86901 | <1% | 64 | $2K | |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 12 | $2K |
| D9310 | <1% | 12 | $2K | |
| D0240 | <1% | 75 | $2K | |
| 84681 | <1% | 13 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 66 | $1K |
| D0170 | <1% | 24 | $1K | |
| 87081 | <1% | 55 | $1K | |
| D0277 | <1% | 14 | $1K | |
| D1320 | <1% | 29 | $1K | |
| 84436 | <1% | 85 | $876.64 | |
| 84479 | <1% | 86 | $824.66 | |
| 0002A | <1% | 42 | $759.60 | |
| 82950 | <1% | 51 | $720.88 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 19 | $707.42 |
| 83735 | <1% | 12 | $673.72 | |
| 36416 | <1% | 39 | $647.90 | |
| 87400 | <1% | 29 | $563.20 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 12 | $534.87 |
| 83550 | <1% | 13 | $521.61 | |
| 99490 | Ccm add 20min | <1% | 235 | $503.22 |
| 83540 | <1% | 16 | $417.43 | |
| 92015 | Determination of refractive state | <1% | 24 | $348.53 |
| 85660 | <1% | 23 | $334.72 | |
| 90670 | <1% | 231 | $290.72 | |
| 99491 | Ccm add 20min | <1% | 17 | $269.37 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 42 | $151.60 |
| 96130 | <1% | 87 | $133.45 | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | <1% | 14 | $125.64 |
| 85041 | <1% | 14 | $12.10 | |
| 0013A | <1% | 107 | $0.01 | |
| D0603 | 0% | 2,685 | $0.00 | |
| 90723 | 0% | 72 | $0.00 | |
| 90647 | 0% | 87 | $0.00 | |
| D0602 | 0% | 354 | $0.00 | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 0% | 39 | $0.00 |
| D0601 | 0% | 254 | $0.00 | |
| 90698 | 0% | 22 | $0.00 | |
| 91301 | 0% | 103 | $0.00 | |
| 90686 | 0% | 115 | $0.00 | |
| 90716 | 0% | 28 | $0.00 | |
| D4346 | 0% | 13 | $0.00 | |
| D9210 | 0% | 13 | $0.00 | |
| 94760 | 0% | 13 | $0.00 | |
| 90674 | 0% | 17 | $0.00 | |
| 90707 | 0% | 70 | $0.00 | |
| 90710 | 0% | 46 | $0.00 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 13 | $0.00 |
| 90633 | 0% | 52 | $0.00 | |
| 90649 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPRAUVE-WEBSTER, MASSERAE (EXECUTIVE DIRECTOR)